Futura Medical (LON:FUM) Receives “Buy” Rating from Liberum Capital

Share on StockTwits

Futura Medical (LON:FUM)‘s stock had its “buy” rating restated by investment analysts at Liberum Capital in a report issued on Tuesday, ThisIsMoney.Co.Uk reports.

LON:FUM opened at GBX 28.50 ($0.37) on Tuesday. Futura Medical has a one year low of GBX 5.65 ($0.07) and a one year high of GBX 47.90 ($0.63). The business’s 50-day simple moving average is GBX 43.26 and its 200 day simple moving average is GBX 27.65. The stock has a market cap of $58.32 million and a price-to-earnings ratio of -6.33.

Futura Medical Company Profile

Futura Medical plc develops pharmaceutical drugs and medical devices for the consumer healthcare markets focusing on sexual healthcare and pain relief management. The company offers CSD500, a condom that incorporates an erectogenic gel to help men maintain a firmer erection during intercourse whilst wearing a condom.

Featured Article: What are trading strategies for the 52-week high/low?

Receive News & Ratings for Futura Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Nanometrics  Lifted to Hold at BidaskClub
Nanometrics Lifted to Hold at BidaskClub
Nasdaq  Downgraded by BidaskClub
Nasdaq Downgraded by BidaskClub
NetScout Systems  Raised to “Hold” at BidaskClub
NetScout Systems Raised to “Hold” at BidaskClub
Intellia Therapeutics  Raised to Hold at BidaskClub
Intellia Therapeutics Raised to Hold at BidaskClub
Northern Trust  Lifted to “Hold” at BidaskClub
Northern Trust Lifted to “Hold” at BidaskClub
Liberty Latin America  Upgraded at BidaskClub
Liberty Latin America Upgraded at BidaskClub


© 2006-2019 Ticker Report